Clinical Trials Logo

Abdominal Abscess clinical trials

View clinical trials related to Abdominal Abscess.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06227871 Completed - Anastomotic Leak Clinical Trials

A Retrospective Analysis of Pancreatic Injuries and Treatment Outcomes

Start date: November 1, 2019
Phase:
Study type: Observational

The goal of this observational study is to compare the presentation, treatment, and outcomes in patients suffering traumatic pancreatic injuries from blunt or penetrating trauma. The questions this study aims to answer are: 1. Does a statistically significant association exist between pancreatic injury grade and the following individual factors: - Mortality - Morbidity - Injury severity score 2. Is there an association between post-operative pancreatic complications and operation-specific intervention? 3. Does pancreatic injury score correlate with certain intra-abdominal organ injuries? Participants meeting criteria are greater than 18 years old, with no history of pancreatic surgery who were hospitalized at Kern Medical Center after presenting to the institution's emergency department as tier 1 or 2 trauma activations following blunt or penetrating abdominal injury and were diagnosed with pancreatic injury during the same hospitalization.

NCT ID: NCT05283733 Completed - Sepsis Clinical Trials

Open to Laparoscopic Reverse Conversion of Perforated Appendicitis

reverse
Start date: January 18, 2018
Phase: N/A
Study type: Interventional

A Prospective Randomized Controlled Trial of Reverse Conversion (Open to Laparoscopic) in management of Acute Perforated Appendicitis

NCT ID: NCT05147870 Completed - Pneumonia Clinical Trials

Outcome After Laparoscopic Surgery for Peptic Ulcer Perforation

Start date: January 1, 2013
Phase:
Study type: Observational

Despite advances in laparoscopic surgery for perforated peptic ulcer (PPU), intra-abdominal abscess (IAA) is recognized as one of the commonly reported complications with relation to the extent of infectious abdominal contamination. Herein, the investigators report their experience of laparoscopic surgery for PPU with/without peritoneal irrigation and discuss postoperative outcome. The investigators retrospectively examined the electronic medical records of the patients who underwent laparoscopic surgery for perforated peptic ulcer at a single medical center in Taiwan between January 2013 and August 2021. Retrospectively, the investigators would include those patients with clinical diagnosis of PPU who underwent emergent laparoscopic surgery. The patients with previous abdominal surgery, pathologic confirmed malignant ulcer perforation or concomitant ulcer bleeding were excluded. The investigators focused on post-operative complications and outcome after laparoscopic surgery with or without peritoneal irrigation. This information can be important in improving surgical options with respect to risk and potential benefits in this setting.

NCT ID: NCT05011630 Completed - Clinical trials for Intraabdominal Abscess After Procedure

Specific Bile Microorganisms Caused Intra-abdominal Abscess on Pancreaticoduodenectomy Patients: Customized Antibiotics And Antifungal Medication May Be Necessary

Start date: January 1, 2007
Phase:
Study type: Observational

Background Intra-abdominal abscess (IAA) is one of the most serious surgical infectious complications on pancreaticoduodenectomy (PD) patients. Preoperative biliary drainage (PBD) is considered as a risk of surgical infectious complications. However, the reason why PBD caused IAA was unknown. In this study, we hypothesize that bile contamination may increase the rate of IAA as bile from residual common bile duct (CBD) leaks and contaminates the abdominal cavity. Methods We retrospectively collected PD patients with performance of bile culture between 2007 and 2019 in our institute. As to bile culture, we used a swab to do intraoperative bile cultures after transection of the CBD. IAA was defined as a postoperative fluid collection managed by CT-guided placement of drains with documental bacteriological culture.

NCT ID: NCT03681665 Completed - Abdominal Abscess Clinical Trials

Use of Iterative Reconstruction Method in Ultralow-dose CT for Follow-up of Patients With Intraabdominal Abscess: Comparison With Standard Dose CT

Start date: June 29, 2018
Phase:
Study type: Observational

Increasing radiation exposure by medical examinations is getting more concerns. For optimal medical imaging, reducing radiation exposure with preservation image quality is important. One of the solutions is use of iterative recontruction of CT examination. In this study, the investigators aimed to investigate the clinical feasibility of ultralow dose abdominopelvic CT with iterative reconstruction in patients with intraabdominal abscess. Patients with intrabdominal abscess usually undergo multiple CT examinations to evaluate treatment response. Therefore, ultralow dose CT can reduce unnecessary radiation exposure in these patients.

NCT ID: NCT01657565 Completed - Wound Infection Clinical Trials

Appendectomy in Children Performed by Residents in the Era of Laparoscopic Surgery

Start date: January 2006
Phase: N/A
Study type: Observational

Introduction: An increasing proportion of childhood appendicitis is treated with laparoscopic appendectomy (LA). The investigators wanted to elucidate the outcome of childhood appendicitis treated primarily by residents in a university hospital. Material and methods: All children (age<16 years) treated surgically with appendectomy in our department between January 2006 and January 2011 were retrospectively identified. Readmission, reoperation or postoperative length of stay (LOS) exceeding five days were considered as non-satisfactory outcomes.

NCT ID: NCT01597336 Completed - Abdominal Abscess Clinical Trials

Treatment of Abdominal Abscesses With or Without Fibrinolysis

Start date: June 2009
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the utility of fibrinolysis when draining an abdominal abscess as defined by length of stay after drainage.

NCT ID: NCT01568853 Completed - Severe Sepsis Clinical Trials

A Prospective Study of The Complement Depletion in Patients With Severe Abdominal Sepsis

Start date: November 2011
Phase: N/A
Study type: Interventional

The role of complement system in bridging innate and adaptive immunity has been confirmed in various invasive pathogens. The aim of this study is to investigate the alteration of complement C3 in patients with severe abdominal sepsis and evaluate the role of complement C3 depletion in prognosis of such patients. The relationship between complement C3 depletion and adaptive immunity is studied meanwhile.

NCT ID: NCT01283815 Completed - Appendicitis Clinical Trials

Laparoscopic Management of Periappendicular Abscess

Start date: January 2011
Phase: Phase 2
Study type: Interventional

According to retrospective studies the conservative management of periappendicular abscess is associated with decreased complication and re-operation rate compared with open appendectomy. Large abscesses require percutaneous drainage. Sometimes percutaneous drainage is not possible because of anatomical position of the abscess and surgical treatment is needed. The purpose of this study is evaluate whether laparoscopic appendectomy is suitable for the first-line treatment in patients with periappendicular abscess. The hypothesis of the study is that laparoscopic management of periappendicular abscess is suitable for the first-line treatment and it does not increase time of hospitalization or complication rate compared with conservative management.

NCT ID: NCT01096511 Completed - Clinical trials for Abscess, Intra-Abdominal

Moxifloxacin i.v. in the Treatment of Complicated Intra-Abdominal Infection (cIAI)

Start date: December 2009
Phase: N/A
Study type: Observational

This study is a local, prospective, open-label, company-sponsored, non interventional, multi-center study. Patients documented must suffer from a cIAI and take at least one dose of Moxifloxacin infusion.The primary objective is to define the types of cIAI infections that require Moxifloxacin i.v. therapy in China.